Rapid communication Open Access
Like 0


We present a global analysis of the spread of recently emerged SARS-CoV-2 variants and estimate changes in effective reproduction numbers at country-specific level using sequence data from GISAID. Nearly all investigated countries demonstrated rapid replacement of previously circulating lineages by the World Health Organization-designated variants of concern, with estimated transmissibility increases of 29% (95% CI: 24–33), 25% (95% CI: 20–30), 38% (95% CI: 29–48) and 97% (95% CI: 76–117), respectively, for B.1.1.7, B.1.351, P.1 and B.1.617.2.


Article metrics loading...

Loading full text...

Full text loading...



  1. World Health Organization (WHO). COVID-19 weekly epidemiological update, 1 June 2021. Geneva: WHO; 2021. Available from: https://apps.who.int/iris/handle/10665/341622
  2. Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob Chall. 2017;1(1):33-46.  https://doi.org/10.1002/gch2.1018  PMID: 31565258 
  3. Department of Health and Social Care. New measures to boost response to the B1.617.2 variant. Press release. London: GOV.UK; 13 May 2021. Available from: https://www.gov.uk/government/news/new-measures-to-boost-response-to-the-b16172-variant
  4. Centers for Disease Control and Prevention (CDC). COVID data tracker. Atlanta: CDC. [Accessed: 13 Apr 2021]. Available from: https://covid.cdc.gov/covid-data-tracker
  5. Public Health England (PHE). Investigation of novel SARS-CoV-2 variants of concern: technical briefings. London: PHE; 2021. [Accessed: 13 Apr 2021]. Available from: https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201
  6. Public Health England (PHE). SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 15. London: PHE; 11 June 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993198/Variants_of_Concern_VOC_Technical_Briefing.pdf
  7. Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. N Engl J Med. 2021;384(20):1885-98.  https://doi.org/10.1056/NEJMoa2102214  PMID: 33725432 
  8. World Health Organization (WHO). Considerations for implementing and adjusting public health and social measures in the context of COVID-19: interim guidance, 4 November 2020. Geneva: WHO; 2020. Available from: https://apps.who.int/iris/handle/10665/336374
  9. Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055.  https://doi.org/10.1126/science.abg3055  PMID: 33658326 
  10. Hodgson D, Flasche S, Jit M, Kucharski AJ, CMMID COVID-19 Working Group, Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group. The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro Surveill. 2021;26(20):2100428.  https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428  PMID: 34018481 
  11. Davies NG, Jarvis CI, Edmunds WJ, Jewell NP, Diaz-Ordaz K, Keogh RH, et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature. 2021;593(7858):270-4.  https://doi.org/10.1038/s41586-021-03426-1  PMID: 33723411 
  12. World Health Organization (WHO). COVID-19 weekly epidemiological update, 13 April 2021. Geneva: WHO; 2021. Available from: https://apps.who.int/iris/handle/10665/340826

Data & Media loading...

Supplementary data

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error